Elanco Animal Health Inc

For the period ended Jun 30, 2024. Filed Aug 8, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 8, 2024

ELAN$26.76-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

	June 30, 2024	December 31, 2023
(Unaudited)
Assets
Current Assets
Cash and cash equivalents	$416	$352
Accounts receivable, net	999	842
Other receivables	81	168
Inventories	1,611	1,735
Prepaid expenses and other	277	310
Assets held for sale	627	—
Total current assets	4,011	3,407
Noncurrent Assets
Goodwill	4,480	5,094
Other intangibles, net	4,000	4,494
Other noncurrent assets	324	341
Property and equipment, net	949	1,026
Total assets	$13,764	$14,362
Liabilities and Equity
Current Liabilities
Accounts payable	$291	$270
Sales rebates and discounts	356	367
Current portion of long-term debt	213	38
Other current liabilities	510	566
Total current liabilities	1,370	1,241
Noncurrent Liabilities
Long-term debt	5,463	5,736
Deferred taxes	524	567
Other noncurrent liabilities	465	595
Total liabilities	7,822	8,139
Commitments and Contingencies
Equity
Common stock, no par value, 5,000,000,000 shares authorized, 494,182,138 and 492,845,216 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	—	—
Additional paid-in capital	8,790	8,777
Accumulated deficit	(2,306)	(2,288)
Accumulated other comprehensive loss	(542)	(266)
Total equity	5,942	6,223
Total liabilities and equity	$13,764	$14,362

2024 Q2 Form 10-Q | 6

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.